BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND MAFB, Q9Y5Q3, 9935, ENSG00000204103, MGC43127, KRML
7 results:

  • 1. Involvement of mafb and MAFF in Retinoid-Mediated Suppression of Hepatocellular Carcinoma Invasion.
    Tsuchiya H; Oura S
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29757260
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Transcription Factor mafb Promotes Hepatocellular Carcinoma Cell Proliferation through Up-Regulation of Cyclin D1.
    Yu H; Jiang HL; Xu D; Jin JZ; Zhao ZM; Ma YD; Liang J
    Cell Physiol Biochem; 2016; 39(2):700-8. PubMed ID: 27448450
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer.
    Simpson DR; Martínez ME; Gupta S; Hattangadi-Gluth J; Mell LK; Heestand G; Fanta P; Ramamoorthy S; Le QT; Murphy JD
    J Natl Cancer Inst; 2013 Dec; 105(23):1814-20. PubMed ID: 24231453
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Liquid chromatography-tandem mass spectrometry method for quantification of thymidine kinase activity in human serum by monitoring the conversion of 3'-deoxy-3'-fluorothymidine to 3'-deoxy-3'-fluorothymidine monophosphate.
    Faria M; Halquist MS; Kindt E; Li W; Karnes HT; O'Brien PJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():13-20. PubMed ID: 22995377
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Common variants at 30 loci contribute to polygenic dyslipidemia.
    Kathiresan S; Willer CJ; Peloso GM; Demissie S; Musunuru K; Schadt EE; Kaplan L; Bennett D; Li Y; Tanaka T; Voight BF; Bonnycastle LL; Jackson AU; Crawford G; Surti A; Guiducci C; Burtt NP; Parish S; Clarke R; Zelenika D; Kubalanza KA; Morken MA; Scott LJ; Stringham HM; Galan P; Swift AJ; Kuusisto J; Bergman RN; Sundvall J; Laakso M; Ferrucci L; Scheet P; Sanna S; Uda M; Yang Q; Lunetta KL; Dupuis J; de Bakker PI; O'Donnell CJ; Chambers JC; Kooner JS; Hercberg S; Meneton P; Lakatta EG; Scuteri A; Schlessinger D; Tuomilehto J; Collins FS; Groop L; Altshuler D; Collins R; Lathrop GM; Melander O; Salomaa V; Peltonen L; Orho-Melander M; Ordovas JM; Boehnke M; Abecasis GR; Mohlke KL; Cupples LA
    Nat Genet; 2009 Jan; 41(1):56-65. PubMed ID: 19060906
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
    Kirk GD; Lesi OA; Mendy M; Szymañska K; Whittle H; Goedert JJ; Hainaut P; Montesano R
    Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A xeno-transplantable plasma cell leukemia line with a split translocation of the IgH gene.
    Ohbayashi K; Taniwaki M; Ninomiya M; Kiyoi H; Iida S; Ueda R; Naoe T
    Cancer Genet Cytogenet; 2003 Jul; 144(1):31-5. PubMed ID: 12810253
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.